Skip to main content
Top
Published in: BMC Medical Genetics 1/2014

Open Access 01-12-2014 | Case report

LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies

Authors: Claudia Santoro, Giuseppe Pacileo, Giuseppe Limongelli, Saverio Scianguetta, Teresa Giugliano, Giulio Piluso, Fulvio Della Ragione, Mario Cirillo, Giuseppe Mirone, Silverio Perrotta

Published in: BMC Medical Genetics | Issue 1/2014

Login to get access

Abstract

Background

Diagnosis within RASopathies still represents a challenge. Nevertheless, many efforts have been made by clinicians to identify specific clinical features which might help in differentiating one disorder from another. Here, we describe a child initially diagnosed with Neurofibromatosis-Noonan syndrome. The follow-up of the proband, the clinical evaluation of his father together with a gene-by-gene testing approach led us to the proper diagnosis.

Case presentation

We report a 8-year-old male with multiple café-au-lait macules, several lentigines and dysmorphic features that suggest Noonan syndrome initially diagnosed with Neurofibromatosis-Noonan syndrome. However, after a few years of clinical and ophthalmological follow-up, the absence of typical features of Neurofibromatosis type 1 and the lack of NF1 mutation led us to reconsider the original diagnosis. A new examination of the patient and his similarly affected father, who was initially referred as healthy, led us to suspect LEOPARD syndrome, The diagnosis was then confirmed by the occurrence in both patients of a heterozygous mutation c.1403 C > T, p.(Thr468Met), of PTPN11. Subsequently, the proband was also found to have type-1 Arnold-Chiari malformation in association with syringomyelia.

Conclusion

Our experience suggests that differential clinical diagnosis among RASopathies remains ambiguous and raises doubts on the current diagnostic clinical criteria. In some cases, genetic tests represent the only conclusive proof for a correct diagnosis and, consequently, for establishing individual prognosis and providing adequate follow-up. Thus, molecular testing represents an essential tool in differential diagnosis of RASophaties. This view is further strengthened by the increasing accessibility of new sequencing techniques.
Finally, to our knowledge, the described case represents the third report of the occurrence of Arnold Chiari malformation and the second description of syringomyelia with LEOPARD syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stevenson DA, Swensen J, Viskochil DH: Neurofibromatosis Type 1 and Other Syndromes of the Ras Pathway. Neurofibromatosis. Edited by: Kaufmann D. 2008, Basel: Karger, 32-45.CrossRef Stevenson DA, Swensen J, Viskochil DH: Neurofibromatosis Type 1 and Other Syndromes of the Ras Pathway. Neurofibromatosis. Edited by: Kaufmann D. 2008, Basel: Karger, 32-45.CrossRef
2.
go back to reference van der Burgt I: Noonan syndrome. Orphanet J Rare Dis. 2007, 14: 2-4. van der Burgt I: Noonan syndrome. Orphanet J Rare Dis. 2007, 14: 2-4.
4.
5.
go back to reference van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E: Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994, 1: 187-191.CrossRef van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E: Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994, 1: 187-191.CrossRef
6.
go back to reference Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD: PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002, 70: 1555-1563. 10.1086/340847.CrossRefPubMedPubMedCentral Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD: PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002, 70: 1555-1563. 10.1086/340847.CrossRefPubMedPubMedCentral
7.
go back to reference National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Arch Neurol (Chicago). 1988, 45: 575-578.CrossRef National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Arch Neurol (Chicago). 1988, 45: 575-578.CrossRef
8.
go back to reference Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer ML, Eldridge R: NIH conference: neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1990, 113: 39-52. 10.7326/0003-4819-113-1-39.CrossRefPubMed Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer ML, Eldridge R: NIH conference: neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1990, 113: 39-52. 10.7326/0003-4819-113-1-39.CrossRefPubMed
9.
go back to reference De Luca A1, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B: NF1 gene mutations represent the major molecular event underlying neurofibromatosis–Noonan syndrome. Am J Hum Genet. 2005, 77: 1092-1101. 10.1086/498454.CrossRefPubMedPubMedCentral De Luca A1, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, Schirinzi A, Conti E, Zampino G, Battaglia A, Majore S, Rinaldi MM, Carella M, Marino B, Pizzuti A, Digilio MC, Tartaglia M, Dallapiccola B: NF1 gene mutations represent the major molecular event underlying neurofibromatosis–Noonan syndrome. Am J Hum Genet. 2005, 77: 1092-1101. 10.1086/498454.CrossRefPubMedPubMedCentral
10.
go back to reference Gorlin RJ, Anderson RC, Blaw M: Multiple lentigines syndrome. Am J Dis Child. 1969, 17: 652-662.CrossRef Gorlin RJ, Anderson RC, Blaw M: Multiple lentigines syndrome. Am J Dis Child. 1969, 17: 652-662.CrossRef
11.
go back to reference Sarkozy A, Conti E, Digilio MC, Marino B, Morini E, Pacileo G, Wilson M, Calabrò R, Pizzuti A, Dallapiccola B: Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet. 2004, 41 (5): e68-10.1136/jmg.2003.013466.CrossRefPubMedPubMedCentral Sarkozy A, Conti E, Digilio MC, Marino B, Morini E, Pacileo G, Wilson M, Calabrò R, Pizzuti A, Dallapiccola B: Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet. 2004, 41 (5): e68-10.1136/jmg.2003.013466.CrossRefPubMedPubMedCentral
12.
go back to reference Brems H1, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E: Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nature Genet. 2007, 39: 1120-1126. 10.1038/ng2113.CrossRefPubMed Brems H1, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E: Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nature Genet. 2007, 39: 1120-1126. 10.1038/ng2113.CrossRefPubMed
13.
go back to reference Tidyman WE, Rauen KA: The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009, 19: 230-236. 10.1016/j.gde.2009.04.001.CrossRefPubMedPubMedCentral Tidyman WE, Rauen KA: The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009, 19: 230-236. 10.1016/j.gde.2009.04.001.CrossRefPubMedPubMedCentral
14.
go back to reference Messiaen LM1, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000, 15: 541-545. 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N.CrossRefPubMed Messiaen LM1, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000, 15: 541-545. 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N.CrossRefPubMed
15.
go back to reference Aoki Y1, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H, Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nagashima T, Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y: Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet. 2013, 93: 173-180. 10.1016/j.ajhg.2013.05.021.CrossRefPubMedPubMedCentral Aoki Y1, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H, Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nagashima T, Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y: Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet. 2013, 93: 173-180. 10.1016/j.ajhg.2013.05.021.CrossRefPubMedPubMedCentral
16.
go back to reference Martínez-Quintana E, Rodríguez-González F: LEOPARD Syndrome Caused by Tyr279Cys Mutation in the PTPN11 Gene. Mol Syndromol. 2012, 2: 251-253.PubMedPubMedCentral Martínez-Quintana E, Rodríguez-González F: LEOPARD Syndrome Caused by Tyr279Cys Mutation in the PTPN11 Gene. Mol Syndromol. 2012, 2: 251-253.PubMedPubMedCentral
17.
go back to reference Radtke HB, Sebold CD, Allison C, Haidle JL, Schneider G: Neurofibromatosis Type 1 in Genetic Counseling Practice: recommendations of the National Society of Genetic Counselors. J Genet Counsel. 2007, 16: 387-407. 10.1007/s10897-007-9101-8.CrossRef Radtke HB, Sebold CD, Allison C, Haidle JL, Schneider G: Neurofibromatosis Type 1 in Genetic Counseling Practice: recommendations of the National Society of Genetic Counselors. J Genet Counsel. 2007, 16: 387-407. 10.1007/s10897-007-9101-8.CrossRef
18.
go back to reference Ferner RE1, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A: Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007, 44: 81-88. 10.1136/jmg.2007.049122.CrossRefPubMed Ferner RE1, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A: Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007, 44: 81-88. 10.1136/jmg.2007.049122.CrossRefPubMed
19.
go back to reference Wu R, Legius E, Robberecht W, Dumoulin M, Cassiman JJ, Fryns JP: Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Hum Mutat. 1996, 8: 51-56. 10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S.CrossRefPubMed Wu R, Legius E, Robberecht W, Dumoulin M, Cassiman JJ, Fryns JP: Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Hum Mutat. 1996, 8: 51-56. 10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S.CrossRefPubMed
20.
go back to reference Carcavilla A, Pinto I, Muñoz-Pacheco R, Barrio R, Martin-Frías M, Ezquieta B: LEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria. Eur J Pediatr. 2011, 170: 1069-1074. 10.1007/s00431-011-1418-5.CrossRefPubMed Carcavilla A, Pinto I, Muñoz-Pacheco R, Barrio R, Martin-Frías M, Ezquieta B: LEOPARD syndrome (PTPN11, T468M) in three boys fulfilling neurofibromatosis type 1 clinical criteria. Eur J Pediatr. 2011, 170: 1069-1074. 10.1007/s00431-011-1418-5.CrossRefPubMed
21.
go back to reference Nyström AM, Ekvall S, Berglund E, Björkqvist M, Braathen G, Duchen K, Enell H, Holmberg E, Holmlund U, Olsson-Engman M, Annerén G, Bondeson ML: Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders. J Med Genet. 2008, 45: 500-506. 10.1136/jmg.2008.057653.CrossRefPubMed Nyström AM, Ekvall S, Berglund E, Björkqvist M, Braathen G, Duchen K, Enell H, Holmberg E, Holmlund U, Olsson-Engman M, Annerén G, Bondeson ML: Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders. J Med Genet. 2008, 45: 500-506. 10.1136/jmg.2008.057653.CrossRefPubMed
22.
go back to reference Muram TM1, Stevenson DA, Watts-Justice S, Viskochil DH, Carey JC, Mao R, Jackson B: A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1. Am J Med Genet A. 2013, 161A: 467-472.CrossRefPubMed Muram TM1, Stevenson DA, Watts-Justice S, Viskochil DH, Carey JC, Mao R, Jackson B: A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1. Am J Med Genet A. 2013, 161A: 467-472.CrossRefPubMed
23.
go back to reference Lepri FR1, Scavelli R, Digilio MC, Gnazzo M, Grotta S, Dentici ML, Pisaneschi E, Sirleto P, Capolino R, Baban A, Russo S, Franchin T, Angioni A, Dallapiccola B: Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Medical Genetics. 2014, 15: 14-CrossRefPubMedPubMedCentral Lepri FR1, Scavelli R, Digilio MC, Gnazzo M, Grotta S, Dentici ML, Pisaneschi E, Sirleto P, Capolino R, Baban A, Russo S, Franchin T, Angioni A, Dallapiccola B: Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Medical Genetics. 2014, 15: 14-CrossRefPubMedPubMedCentral
24.
go back to reference Beier AD, Barrett RJ, Burke K, Kole B, Soo TM: Leopard syndrome and Chiari type I malformation: a case report and review of the literature. Neurologist. 2009, 15: 37-39. 10.1097/NRL.0b013e31817833c4.CrossRefPubMed Beier AD, Barrett RJ, Burke K, Kole B, Soo TM: Leopard syndrome and Chiari type I malformation: a case report and review of the literature. Neurologist. 2009, 15: 37-39. 10.1097/NRL.0b013e31817833c4.CrossRefPubMed
25.
go back to reference Agha A, Hashimoto K: Multiple lentigines (Leopard) syndrome with Chiara I malformation. J Dermatol. 1995, 22: 520-523.CrossRefPubMed Agha A, Hashimoto K: Multiple lentigines (Leopard) syndrome with Chiara I malformation. J Dermatol. 1995, 22: 520-523.CrossRefPubMed
26.
go back to reference Reinker KA, Stevenson DA, Tsung A: Orthopaedic conditions in Ras/MAPK related disorders. J Pediatr Orthop. 2011, 31: 599-605.CrossRefPubMed Reinker KA, Stevenson DA, Tsung A: Orthopaedic conditions in Ras/MAPK related disorders. J Pediatr Orthop. 2011, 31: 599-605.CrossRefPubMed
27.
go back to reference Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ: Chiari I malformation and neurofibromatosis type 1. Pediatr Neurol. 2004, 30: 278-280. 10.1016/j.pediatrneurol.2003.09.013.CrossRefPubMed Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ: Chiari I malformation and neurofibromatosis type 1. Pediatr Neurol. 2004, 30: 278-280. 10.1016/j.pediatrneurol.2003.09.013.CrossRefPubMed
28.
go back to reference Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberge C, Gewillig M, Fryns JP: PTPN11 mutations in LEOPARD syndrome. J Med Genet. 2002, 39: 571-574. 10.1136/jmg.39.8.571.CrossRefPubMedPubMedCentral Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberge C, Gewillig M, Fryns JP: PTPN11 mutations in LEOPARD syndrome. J Med Genet. 2002, 39: 571-574. 10.1136/jmg.39.8.571.CrossRefPubMedPubMedCentral
Metadata
Title
LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies
Authors
Claudia Santoro
Giuseppe Pacileo
Giuseppe Limongelli
Saverio Scianguetta
Teresa Giugliano
Giulio Piluso
Fulvio Della Ragione
Mario Cirillo
Giuseppe Mirone
Silverio Perrotta
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2014
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-15-44

Other articles of this Issue 1/2014

BMC Medical Genetics 1/2014 Go to the issue